Integrated analysis identifies DUSP5 as a novel prognostic indicator for thyroid follicular carcinoma.
Qian ZhangYiqian XingShan JiangChunmei XuXiaojun ZhouRui ZhangTianyue XieZhiwei ZouPiyun GongHuangao ZhuDongmei ZhangHuimei MaLin LiaoJian Jun DongPublished in: Thoracic cancer (2019)
DUSP5 was differentially expressed in FTC and PTC tissues. Low level of DUSP5 in FTC participates in the high frequency of metastasis, and further contributes to poor prognosis of FTC. DUSP5 could be served as a novel therapeutic target for FTC.